首页> 外文期刊>Journal of Advanced Pharmaceutical Technology Research >New avenue in the treatment of temporal lobe epilepsy by classical anti-epileptics: A hypothetical establishment of executioner Caspase 3 inactivation by molecular modeling
【24h】

New avenue in the treatment of temporal lobe epilepsy by classical anti-epileptics: A hypothetical establishment of executioner Caspase 3 inactivation by molecular modeling

机译:经典抗癫痫药治疗颞叶癫痫的新途径:通过分子建模假想of子半胱天冬酶3的失活

获取原文
       

摘要

Patients with temporal lobe epilepsy (TLE) are prescribed first-line antiepileptic drugs and surgery to the management of this disorder. Unfortunately, the surgical treatment has been shown to be beneficial for the selected patients but fails to provide a seizure-free outcome in 20–30% of TLE patients. In our present study, we investigate the possibilities of marketed antiepileptic drugs in a different manner to improve the present situation in TLE. Molecular docking simulation study and various open source computational tools were used to perform the study. AutoDock 4.2 MGL tools, Pymol visualize tools, Patch dock server, and Swarm Dock servers (protein-protein docking) were used to perform the molecular modeling. FTsite and computed atlas of surface topography of protein open source server were used to understand the pocket and ligand binding information respectively. Toxtree application was used to determine the toxicity profile of the drug by Cramers rule. The obtained molecular docking models (Caspase 3, Procaspase 8, and Fas-associated death domain [FADD]) with selected compounds (Clonazepam, Clobazepam, and Retigabine) showed promising trio blocking event of FADD, Caspase 3, and Procaspase 8 (?6.66 kcal, ?8.1 kcal, 6.46 kcal) by Clonazepam respectively. Protein-protein interaction study (Swarm Dock, Patch Dock server) indicated promising results that helped to establish our hypothesis. Toxtree showed a quantitative structure toxicity relationship report that helps to clarify the toxicity of the selected compounds. Clonazepam showed a trio inhibition property that may lead to develop a new era of the new generation benzodiazepine prototype drugs in the future. Filtered compounds will further process for higher in vitro, in vivo models for better understanding of the mechanism.Keywords: Caspase 3, Fas-associated death domain, Procaspase 8, quantitative structure toxicity relationship, temporal lobe epilepsy
机译:患有颞叶癫痫(TLE)的患者被处方一线抗癫痫药和手术治疗该疾病。不幸的是,手术治疗已被证明对选定的患者有益,但未能为20%至30%的TLE患者提供无癫痫发作的结果。在我们目前的研究中,我们以不同的方式调查了上市抗癫痫药物的可能性,以改善TLE的现状。使用了分子对接模拟研究和各种开源计算工具来进行研究。使用AutoDock 4.2 MGL工具,Pymol可视化工具,Patch Dock服务器和Swarm Dock服务器(蛋白质-蛋白质对接)进行分子建模。 FTsite和蛋白质开源服务器表面形貌计算图谱分别用于理解口袋和配体结合信息。通过Cramers规则,使用Toxtree应用程序确定药物的毒性特征。获得的分子对接模型(Caspase 3,Procaspase 8和Fas相关死亡结构域[FADD])与选定化合物(Clonazepam,Clobazepam和Retigabine)的结合对FADD,Caspase 3和Procaspase 8的三重阻断作用很有前景(?6.66)。氯硝西am(分别为kcal,?8.1 kcal,6.46 kcal)。蛋白质-蛋白质相互作用研究(Swarm Dock,Patch Dock服务器)显示了有希望的结果,有助于建立我们的假设。 Toxtree显示了定量结构毒性关系报告,该报告有助于阐明所选化合物的毒性。氯硝西showed显示出三重抑制特性,可能会导致未来开发新一代苯并二氮杂prototype原型药物的新时代。筛选出的化合物将进一步加工成更高水平的体外,体内模型,以更好地了解其机制。关键词:半胱天冬酶3,Fas相关死亡结构域,前蛋白酶8,定量结构毒性关系,颞叶癫痫

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号